Genzyme Biosurgery
Genzyme Biosurgery,(Genzyme) is a medical device manufacturing company principally engaged in the development, manufacturing and distribution of biotherapeutic and biomaterial products for orthopedic and surgical market. The product portfolio of the company includes cultured epidermal autografts, autologous cultured chondrocytes, sodium hyaluronate, seprafilm adhesion barrier and bulk hyaluronan used to treat osteoarthritis of the knee as well as improve patient outcomes and reduce complications during surgery. It is an operating division of Genzyme Corporation. The company follows several industry standards while manufacturing the products. The company operates its business in Africa, Asia, Australia, Europe, Middle East, North America and South America. Genzyme is headquartered in Massachusetts, the US.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

